120 related articles for article (PubMed ID: 3722818)
1. Activator-bound C1 is less susceptible to inactivation by C1 inhibition than is fluid-phase C1.
Tenner AJ; Frank MM
J Immunol; 1986 Jul; 137(2):625-30. PubMed ID: 3722818
[TBL] [Abstract][Full Text] [Related]
2. A mechanism for the spontaneous activation of the first component of complement, C1, and its regulation by C1-inhibitor.
Bianchino AC; Poon PH; Schumaker VN
J Immunol; 1988 Dec; 141(11):3930-6. PubMed ID: 3183385
[TBL] [Abstract][Full Text] [Related]
3. Antibody-independent C1 activation by E. coli.
Tenner AJ; Ziccardi RJ; Cooper NR
J Immunol; 1984 Aug; 133(2):886-91. PubMed ID: 6376630
[TBL] [Abstract][Full Text] [Related]
4. Surface-bound capsular polysaccharide of type Ia group B Streptococcus mediates C1 binding and activation of the classic complement pathway.
Levy NJ; Kasper DL
J Immunol; 1986 Jun; 136(11):4157-62. PubMed ID: 3517165
[TBL] [Abstract][Full Text] [Related]
5. Characterization of C1q by monoclonal antibodies.
Heinz HP; Loos M
Behring Inst Mitt; 1984 Nov; (76):42-58. PubMed ID: 6335397
[TBL] [Abstract][Full Text] [Related]
6. Activation of the first component of complement, C1, by a monoclonal antibody recognizing the C chain of C1q.
Heinz HP; Burger R; Golan MD; Loos M
J Immunol; 1984 Feb; 132(2):804-8. PubMed ID: 6606678
[TBL] [Abstract][Full Text] [Related]
7. Prevention of immune precipitation by purified classical pathway complement components.
Naama JK; Hamilton AO; Yeung-Laiwah AC; Whaley K
Clin Exp Immunol; 1984 Nov; 58(2):486-92. PubMed ID: 6333948
[TBL] [Abstract][Full Text] [Related]
8. The interaction of human plasma fibronectin with a subunit of the first component of complement, C1q.
Pearlstein E; Sorvillo J; Gigli I
J Immunol; 1982 May; 128(5):2036-9. PubMed ID: 6801128
[TBL] [Abstract][Full Text] [Related]
9. C1- inactivator: its efficiency as a regulator of classical complement pathway activation by soluble IgG aggregates.
Doekes G; van Es LA; Daha MR
Immunology; 1983 Jun; 49(2):215-22. PubMed ID: 6852866
[TBL] [Abstract][Full Text] [Related]
10. Effect of plicatic acid on human serum complement includes interference with C1 inhibitor function.
Giclas PC
J Immunol; 1982 Jul; 129(1):168-72. PubMed ID: 6979566
[TBL] [Abstract][Full Text] [Related]
11. Leukocyte-derived complement inhibitor. IV. The functional properties of C1 bound to erythrocytes pretreated with leukocyte culture supernatant.
Bernard A; Walter W; Teshima H; Boumsell L; Good RA; Day NK
J Immunol; 1976 Oct; 117(4):1117-26. PubMed ID: 977945
[TBL] [Abstract][Full Text] [Related]
12. Potentiation of C1 inhibitor by glycosaminoglycans: dextran sulfate species are effective inhibitors of in vitro complement activation in plasma.
Wuillemin WA; te Velthuis H; Lubbers YT; de Ruig CP; Eldering E; Hack CE
J Immunol; 1997 Aug; 159(4):1953-60. PubMed ID: 9257861
[TBL] [Abstract][Full Text] [Related]
13. Heparin binding and augmentation of C1 inhibitor activity.
Caldwell EE; Andreasen AM; Blietz MA; Serrahn JN; VanderNoot V; Park Y; Yu G; Linhardt RJ; Weiler JM
Arch Biochem Biophys; 1999 Jan; 361(2):215-22. PubMed ID: 9882449
[TBL] [Abstract][Full Text] [Related]
14. Activation of human C1r: Western blot analysis reveals slow and dose-dependent activation.
Hosoi S; Borsos T
J Immunol; 1988 Sep; 141(5):1610-4. PubMed ID: 2842400
[TBL] [Abstract][Full Text] [Related]
15. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
Brown EJ; Ramsey J; Hammer CH; Frank MM
J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
[TBL] [Abstract][Full Text] [Related]
16. Effect of supraphysiologic levels of C1-inhibitor on the classical, lectin and alternative pathways of complement.
Nielsen EW; Waage C; Fure H; Brekke OL; Sfyroera G; Lambris JD; Mollnes TE
Mol Immunol; 2007 Mar; 44(8):1819-26. PubMed ID: 17101176
[TBL] [Abstract][Full Text] [Related]
17. The relationship between the binding ability and the rate of activation of the complement component C1.
Folkerd EJ; Gardner B; Hughes-Jones NC
Immunology; 1980 Sep; 41(1):179-85. PubMed ID: 7429549
[TBL] [Abstract][Full Text] [Related]
18. A sensitive specific hemolytic assay for proenzyme C1.
Tenner AJ; Frank MM
Complement; 1987; 4(1):42-52. PubMed ID: 3552398
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of C1 activation by a monoclonal anti-C1q antibody and its (Fab)2 fragments.
Kilchherr E; Schumaker VN; Bianchino AC; Curtiss LK
J Immunol; 1987 Feb; 138(3):849-55. PubMed ID: 3492535
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous activation of reconstituted and serum C1 and the role of C1-inhibitor.
Schumaker VN; Tseng Y; Poon PH; Bianchino AC; Zavodszky P
Behring Inst Mitt; 1989 Jul; (84):102-10. PubMed ID: 2803179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
